Professor Henry T. "Hank" Greely is quoted in a Washington Post story illuminating the risks and dangers to patients, physicians, and manufacturers of experimental gene therapy drugs:

"Because of the relationship . . . you have to worry that they won't listen carefully enough to the risks," said Hank Greely, director of the Center for Law and the Biosciences at Stanford University. Patients, he said, may think, " 'After all, if my doctor is doing this, it must be good for me.' That can be difficult to overcome with words in a consent form."